# BOTOX® in the Treatment of Upper Facial Lines in Japan

> **NCT01797094** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 101 (actual)

## Conditions studied

- Upper Facial Rhytides
- Crow's Feet Lines
- Glabellar Lines
- Frown Lines

## Interventions

- **BIOLOGICAL:** botulinum toxin Type A (44U)
- **BIOLOGICAL:** botulinum toxin Type A (32U)

## Key facts

- **NCT ID:** NCT01797094
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2013-07
- **Final completion:** 2014-07
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2015-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01797094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01797094, "BOTOX® in the Treatment of Upper Facial Lines in Japan". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01797094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*